MAPT and Alzheimer disease: Lastly, while G-Bro shows promise in inhibiting BACE1 and preventing Aβ aggregation, the interaction with other pathways involved in Alzheimer’s disease pathology, such as tau aggregation or neuroinflammation, was not investigated in this study.